Status:
COMPLETED
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)
Lead Sponsor:
Hellenic Atherosclerosis Society
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
The objective of this protocol is to improve awareness, treatment, and control of metabolic syndrome, within primary prevention of cardiovascular disease, by implementing guidelines, after training of...
Detailed Description
Physicians from 20 hospitals or health centres (primary and secondary health care settings) were trained to implement guidelines in treating metabolic syndrome. There will be a baseline recording of ...
Eligibility Criteria
Inclusion
- Metabolic Syndrome (NCEP ATP III Definition modified to AHA/NHLBI definition)
Exclusion
- Pregnancy
- Lactation
- Malignancies with small life expectancy
- Unwillingness to participate
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00416741
Start Date
February 1 2005
End Date
February 1 2011
Last Update
June 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hellenic Atherosclerosis Society
Thessaloniki, Thessaloniki, Greece, 55132